Jonathan Cebon Selected Research

HLA-C*03 antigen

1/2016

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan Cebon Research Topics

Disease

72	Melanoma (Melanoma, Malignant) 01/2022 - 07/2003
67	Neoplasms (Cancer) 11/2021 - 07/2002
13	Testicular Neoplasms (Testicular Cancer) 11/2018 - 04/2004
9	Disease Progression 12/2021 - 10/2014
8	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2002
6	Inflammation (Inflammations) 01/2020 - 01/2002
5	Infections 11/2010 - 01/2002
5	Human Influenza (Influenza) 11/2010 - 07/2003
4	Fever (Fevers) 09/2017 - 06/2007
4	Fatigue 09/2017 - 06/2007
3	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 07/2002
2	Hutchinson's Melanotic Freckle (Lentigo Maligna) 01/2020 - 01/2015
2	Brain Neoplasms (Brain Tumor) 10/2019 - 06/2017
2	Rheumatic Diseases (Rheumatism) 02/2019 - 12/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 07/2004
2	Exanthema (Rash) 04/2016 - 04/2009
2	Carcinogenesis 01/2015 - 07/2004
2	Breast Neoplasms (Breast Cancer) 08/2009 - 07/2004
2	Virus Diseases (Viral Diseases) 03/2008 - 02/2004
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Hepatitis 12/2021
1	Adrenocortical Carcinoma 12/2021
1	Malignant Mesothelioma 05/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Carcinoid Tumor (Carcinoid) 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Acute Tubulointerstitial Nephritis 01/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Uveal melanoma 01/2019
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019

Drug/Important Bio-Agent (IBA)

33	AntigensIBA 04/2021 - 07/2002
14	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2002
11	IpilimumabIBA 12/2021 - 04/2009
11	Peptides (Polypeptides)IBA 04/2021 - 09/2002
11	EpitopesIBA 11/2018 - 09/2002
11	VaccinesIBA 04/2015 - 04/2004
10	NivolumabIBA 12/2021 - 06/2017
10	Neoplasm Antigens (Tumor Antigens)IBA 11/2018 - 04/2004
8	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
8	Cancer VaccinesIBA 12/2018 - 02/2009
7	AntibodiesIBA 04/2021 - 07/2004
7	dabrafenibIBA 10/2019 - 11/2012
7	MART-1 AntigenIBA 01/2012 - 07/2003
6	Pharmaceutical PreparationsIBA 01/2019 - 10/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2012
5	pembrolizumabIBA 01/2021 - 06/2017
5	trametinibIBA 01/2018 - 11/2012
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 11/2012
5	ISCOMATRIXIBA 03/2009 - 04/2004
4	Programmed Cell Death 1 ReceptorIBA 11/2021 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2007
3	B7-H1 AntigenIBA 11/2021 - 09/2017
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 09/2006
3	LigandsIBA 12/2018 - 09/2004
3	AutoantibodiesIBA 01/2018 - 07/2002
3	Phosphotransferases (Kinase)IBA 11/2017 - 08/2014
3	Small Interfering RNA (siRNA)IBA 07/2016 - 07/2014
3	Biological ProductsIBA 01/2016 - 06/2003
3	NucleotidesIBA 12/2015 - 07/2003
3	Complementary DNA (cDNA)IBA 07/2013 - 07/2002
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2009 - 09/2002
3	CytokinesIBA 09/2006 - 04/2002
3	CD40 Ligand (CD40L)IBA 09/2006 - 01/2002
3	Monophenol Monooxygenase (Tyrosinase)IBA 02/2006 - 09/2004
2	Cisplatin (Platino)FDA LinkGeneric 05/2021 - 01/2019
2	Imiquimod (Aldara)FDA LinkGeneric 01/2020 - 09/2004
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 03/2016
2	Mitogen-Activated Protein KinasesIBA 11/2017 - 01/2017
2	Cyclin B1IBA 11/2016 - 05/2013
2	EnzymesIBA 04/2016 - 02/2016
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2016 - 08/2013
2	Differentiation AntigensIBA 07/2010 - 02/2006
2	interleukin-21 (interleukin 21)IBA 03/2009 - 06/2007
2	Antigen-Antibody Complex (Immune Complex)IBA 02/2009 - 09/2002
2	Amino Acids FDA Link 02/2009 - 04/2004
2	Interferon Type IIBA 03/2008 - 02/2004
2	flt3 ligand protein (flt3 ligand)IBA 09/2006 - 09/2004
2	influenza matrix peptide (58-66)IBA 03/2005 - 07/2003
1	AZD4320IBA 05/2021
1	Pemetrexed (MTA)FDA Link 05/2021
1	AZD5991IBA 05/2021
1	AZD0466IBA 05/2021
1	Dendrimers (Dendrons)IBA 05/2021
1	Lysine (L-Lysine)FDA Link 05/2021
1	CTLA-4 AntigenIBA 04/2021
1	SteroidsIBA 01/2020
1	CreatinineIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Yttrium-90IBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	C-PeptideIBA 01/2019

Therapy/Procedure

38	Therapeutics 01/2022 - 01/2003
21	Immunotherapy 01/2022 - 01/2003
7	Drug Therapy (Chemotherapy) 01/2022 - 08/2006
4	Transplantation 07/2016 - 01/2003
2	Radiotherapy 12/2016 - 01/2014
1	Microspheres (Microsphere) 01/2019